Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the Common Cold

Stopped did not enroll enough subjects in the 2017/2018 cold season, so the study was terminated

Conditions

• Common Cold

Interventions

• DRUG: New Formulation Phenylephrine HCl
• DRUG: Marketed Phenylephrine HCl
• DRUG: Placebo

Sponsor

Johnson & Johnson Consumer Inc. (J&JCI)